Key Players: SCHOTT Pharma, Gerresheimer AG and West Pharmaceutical Services
Chuyn ha: Khng c thng tin
While the maximum dose is 15 mg, some individuals may find 7.5 mg or 10 mg sufficient if they achieve good results with manageable side effects
Market Segment Insights The market displays a notable distribution among its segment types, notably 'Short-acting', 'Long-acting', and 'Dual-action'
Injecting at the same time each week keeps those levels as stable as possible, which reduces the likelihood of breakthrough side effects from concentration peaks and valleys
Its unique triple-agonist mechanism targeting GLP-1, GIP, and glucagon receptors positions it as a powerhouse in metabolic research